| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;100:2284.)
© 1999 American Heart Association, Inc.
AHA Scientific Statement |
Magnetic Resonance Angiography
Update on Applications for Extracranial Arteries
Key Words: AHA Scientific Statement • angiography • magnetic resonance imaging • imaging • arteries
Magnetic resonance angiography (MRA) has excited the interest of many physicians working in cardiovascular disease because of its ability to noninvasively visualize vascular disease. Its potential to replace conventional x-ray angiography (CA) that uses iodinated contrast has been recognized for many years, and this interest has been stimulated by the current emphasis on cost containment, outpatient evaluation, and minimally invasive diagnosis and therapy. In addition, recent advances in magnetic resonance (MR) technology resulting from fast gradients and use of contrast agents have allowed MRA to make substantial advances in many arterial beds of clinical interest. The goal of this scientific statement is to present the current state of MRA of the extracranial arteries and to suggest current as well as possible future clinical applications for MRA. For the purposes of this statement, MRA is defined as MR techniques that provide cross-sectional or projectional images of normal and diseased arterial anatomy. It does not deal with the equally important area of quantitative flow measurement with MR. The first section deals with the technical basis of MRA. Subsequent sections deal with individual vascular beds in which MRA has shown clinical promise.
MRA: Technical Considerations
The "gold standard" for many manifestations of vascular
disease, especially arterial occlusive disease, is CA, an
invasive, costly, and potentially hazardous procedure. MRA could
represent an alternative, noninvasive approach. Rather than a
single technique, MRA actually represents a family of different
techniques. As outlined below, contrast between blood and soft tissues
is derived from completely different MR mechanisms in the various
This article has been cited by other articles:
 |
|
 |
|
  R. E. Latchaw, M. J. Alberts, M. H. Lev, J. J. Connors, R. E. Harbaugh, R. T. Higashida, R. Hobson, C. S. Kidwell, W. J. Koroshetz, V. Mathews, et al. Recommendations for Imaging of Acute Ischemic Stroke: A Scientific Statement From the American Heart Association Stroke, November 1, 2009; 40(11): 3646 - 3678. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Creager, C. J. White, W. R. Hiatt, M. H. Criqui, S. C. Josephs, M. J. Alberts, W. H. Pearce, B. H. Gray, and K. J. Rocha-Singh Atherosclerotic Peripheral Vascular Disease Symposium II: Executive Summary Circulation, December 16, 2008; 118(25): 2811 - 2825. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Runck, R.P. Steiner, W.A. Bautz, and M.M. Lell MR Imaging: Influence of Imaging Technique and Postprocessing on Measurement of Internal Carotid Artery Stenosis AJNR Am. J. Neuroradiol., October 1, 2008; 29(9): 1736 - 1742. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gharib, V. B. Ho, D. R. Rosing, D. A. Herzka, M. Stuber, A. E. Arai, and R. I. Pettigrew Coronary Artery Anomalies and Variants: Technical Feasibility of Assessment with Coronary MR Angiography at 3 T Radiology, April 1, 2008; 247(1): 220 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Saba and G. Mallarini MDCTA of Carotid Plaque Degree of Stenosis: Evaluation of Interobserver Agreement Am. J. Roentgenol., January 1, 2008; 190(1): W41 - W46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Bondy, P. L. Van, V. K. Bakalov, and V. B. Ho Growth Hormone Treatment and Aortic Dimensions in Turner Syndrome J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1785 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Bunce, C. H. Lorenz, J. Keegan, J. Lesser, E. M. Reyes, D. N. Firmin, and D. J. Pennell Coronary Artery Anomalies: Assessment with Free-breathing Three-dimensional Coronary MR Angiography Radiology, April 1, 2003; 227(1): 201 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wyttenbach, S. Gianella, M. Alerci, A. Braghetti, L. Cozzi, and A. Gallino Prospective Blinded Evaluation of Gd-DOTA- versus Gd-BOPTA-enhanced Peripheral MR Angiography, as Compared with Digital Subtraction Angiography Radiology, April 1, 2003; 227(1): 261 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Geva, G. F. Greil, A. C. Marshall, M. Landzberg, and A. J. Powell Gadolinium-Enhanced 3-Dimensional Magnetic Resonance Angiography of Pulmonary Blood Supply in Patients With Complex Pulmonary Stenosis or Atresia: Comparison With X-Ray Angiography Circulation, July 23, 2002; 106(4): 473 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Greil, A. J. Powell, H. P. Gildein, and T. Geva Gadolinium-enhanced three-dimensional magnetic resonance angiography of pulmonary and systemic venous anomalies J. Am. Coll. Cardiol., January 16, 2002; 39(2): 335 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. A. Fayad and V. Fuster Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque Circ. Res., August 17, 2001; 89(4): 305 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Lipton, L. M. Boxt, and Z. M. Hijazi Role of the Radiologist in Cardiac Diagnostic Imaging Am. J. Roentgenol., December 1, 2000; 175(6): 1495 - 1506. [Full Text] [PDF]
|
|